Interní Med. 2003; 5(1): 19-23

Toxické poškození jater - II. díl

prof. MUDr. Marie Brodanová DrSc
I. interní klinika 1. LF UK a VFN Praha

Keywords: hepatotoxicity, hepatitis-like injury, cholestasis, acetaminophen, therapy of hepatotoxic damage.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brodanová M. Toxické poškození jater - II. díl. Interní Med. 2003;5(1):19-23.

V okolním prostředí roste počet látek i léků, které jsou buď přímo, nebo potenciálně toxické. Játra jsou hlavním orgánem látkové přeměny v organizmu a hrají hlavní úlohu i v metabolizmu xenobiotik. Musíme tedy počítat s jejich častějším poškozením nejrůznějšími hepatotoxickými látkami. V krátkosti jsou probrány nejdůležitější mechanizmy poškození hepatocytů i žlučovodů. Poškození chemikáliemi jsou uvedena jen v přehledu, hlavní pozornost je věnována nejčastějším polékovým lézím, a to jak formě napodobující zánět jater (hepatititis-like) tak formě cholestatické. Detailněji je probrána intoxikace paracetamolem, neboť s ní se dnes setkáváme častěji. Pozornost je věnována možnostem diagnostickým i terapeutickým.

TOXIC DAMAGE TO THE LIVER

In the environment an increase in the number of substances and drugs, which are either directly or potentially toxic, has been noted. The liver is the major metabolizing organ of the body and is responsible for such processes as the metabolism of xenobiotics. Therefore, the liver is very frequently damaged by various hepatotoxic agents. A brief description of the most important mechanisms of injury to liver cells and bile ducts is offered. Damage by chemicals is only described as a survey, but the main attention is focused on the most common drug lesions, such as those caused by hepatitis and cholestasis. Intoxication by acetaminophen is described in detail, because we may encounter this more frequently. Attention is given to both the diagnostic and therapeutic managements.

Download citation

References

  1. Aithal GP, Rawlins MD, Day ChP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatology 2000; 6: 949-952. Go to original source... Go to PubMed...
  2. Brodanová M, Kordač V. Klinická hepatologie. Grada-Avicenum Praha 1993; 549.
  3. Brodanová M. Toxické poškození jater. Aventis Praha 2001: 51.
  4. Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatology 1997; 26(Suppl. 1): 31-35. Go to original source... Go to PubMed...
  5. Erlinger S. Drug-induced cholestasis. J Hepatology 1997; 26(Suppl. 1): 1-4. Go to original source... Go to PubMed...
  6. Farrell GC. Editor: Drug-induced acute hepatitis. V Drug induced liver disease. Churchill Livingstone, London, 1994: 262-269.
  7. Kenna G. Immunoallergig drug-induced hepatitis: lessions from halothane. J Hepatology 1997; 26(Suppl. 1): 5-12. Go to original source... Go to PubMed...
  8. Krahenbuhl S. Mitochondria: important target for drug toxicity? J Hepatology 2001; 2: 334-336. Go to original source... Go to PubMed...
  9. Kuntz E. Leber und Umwelt. Toxische Leberschaden. Nattermann, Frankfurt/ Main 1986: 100.
  10. Larrey D. Hepatotoxicity of herbal remedies. arrey D. Hepatotoxicity of herbal remedies. J Hepatology 1997; 26(Suppl. 1): 47-51. Go to original source... Go to PubMed...
  11. Larrey D. Drug-induces liver diseases. J Hepatology 2000; 1: 77-88. Go to original source... Go to PubMed...
  12. Lee WM. Assesing causality in drug-induced liver injury. J Hepatology 2000; 6: 1003-1005. Go to original source... Go to PubMed...
  13. O´Grady JG. Paracetamol-induced acute liver failure: Prevention and management. J Hepatology 1977; 26(Suppl. 1): 41-46. Go to original source... Go to PubMed...
  14. Pessayre D. Role of reactive metabolites in drug - induced hepatitis. J Hepatology 1995; (Suppl.1): 16-24. Go to original source...
  15. Reichen J. Prescribing in liver disease. J Hepatology 1997; 26(Suppl-1): 36-40. Go to original source... Go to PubMed...
  16. Sechser T. Farmakoterapie u pacientů s onemocněním jater. Č hepato-pankreato-biliární chirurgie. 2002; 2-3: 58-59.
  17. Schenker S, Martin RR, Hoyumpa AM. Antecedent liver disease and drug toxicity. J Hepatology 1999; 6: 1098-1105. Go to original source... Go to PubMed...
  18. Schiff L, Schiff ER, editors. Diseases of the liver. 6th ed. JB Lippincott Company, Philadelphia, London, Mexico City s1506.
  19. Thaler H. Leberkrankheiten. Klinische-morphologische Diagnostik und ihre Grundlagen. Springer Verlag Berlin 1987: 517. Go to original source...
  20. Zimmerman HJ, Maddrey WC. Toxic and drug induced hepatitis. V Schiff L, Schiff ER, editors. Diseases of the Liver. 7th ed., Vol I Chap 28 s. 707-783 JB Lippicott, Philadelphia 1993: 1696.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.